Status:
NOT_YET_RECRUITING
The LARC Robot Simplifies Renal Access In Percutaneous Nephrolithotomy
Lead Sponsor:
AdventHealth
Conditions:
Renal Stone Disease
Kidney Calculi
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is being done to evaluate a new robotic system that helps urologists more precisely reach the kidney during surgery to remove large kidney stones. The procedure, called percutaneous nephrol...
Eligibility Criteria
Inclusion
- Kidney stones larger than 2 cm
- Staghorn renal calculi
- Lower pole stones less than 2 cm
- Anatomical abnormalities that reduce the likelihood of spontaneous stone fragment passage, such as:
- Horseshoe kidney
- Calyceal diverticulum
- Ectopic or dystopic kidney
- Stones that are refractory to prior treatment (e.g., ESWL or ureteroscopy)
- Suspected malignant tumors or masses located in the planned renal access tract
Exclusion
- Pregnancy
- Active urinary tract infection (UTI) or untreated sepsis
- Known bleeding disorders or uncorrectable coagulopathy despite medical management
- Use of anticoagulant medications (e.g., warfarin, heparin, or DOACs) that cannot be safely discontinued
- Allergy to contrast media that cannot be pre-medicated or managed
- Severe cardiopulmonary comorbidities that contraindicate anesthesia or PCNL
- Inability to provide informed consent
- Participation in another investigational study that may interfere with study outcomes
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT07211555
Start Date
November 1 2025
End Date
January 1 2026
Last Update
October 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Advent Health Medical Group Urology at Celebration
Celebration, Florida, United States, 34747